For the second quarter ended June 30, Novartis' $10.73 billion in sales was spurred in part by an 11.9 percent jump in sales in its Consumer Health operation, which climbed to $1.53 billion. The division's performance was led by CIBA Vision, which saw improvements over the same period last year ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.